These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 33973693)

  • 1. Spatial Covariance of Cholinergic Muscarinic M
    Colloby SJ; Nathan PJ; Bakker G; Lawson RA; Yarnall AJ; Burn DJ; O'Brien JT; Taylor JP
    Mov Disord; 2021 Aug; 36(8):1879-1888. PubMed ID: 33973693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic muscarinic M
    Colloby SJ; Nathan PJ; McKeith IG; Bakker G; O'Brien JT; Taylor JP
    Brain Commun; 2020; 2(2):fcaa098. PubMed ID: 32954342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic and perfusion brain networks in Parkinson disease dementia.
    Colloby SJ; McKeith IG; Burn DJ; Wyper DJ; O'Brien JT; Taylor JP
    Neurology; 2016 Jul; 87(2):178-85. PubMed ID: 27306636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.
    Colloby SJ; McKeith IG; Wyper DJ; O'Brien JT; Taylor JP
    J Neurol; 2015 Sep; 262(9):2144-53. PubMed ID: 26122542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A spatial covariance
    Colloby SJ; Field RH; Wyper DJ; O'Brien JT; Taylor JP
    Neurobiol Aging; 2016 Nov; 47():83-90. PubMed ID: 27565302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease.
    van der Zee S; Müller MLTM; Kanel P; van Laar T; Bohnen NI
    Mov Disord; 2021 Mar; 36(3):642-650. PubMed ID: 33137238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT.
    Pakrasi S; Colloby SJ; Firbank MJ; Perry EK; Wyper DJ; Owens J; McKeith IG; Williams ED; O'Brien JT
    J Neurol; 2007 Jul; 254(7):907-13. PubMed ID: 17361343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment.
    van der Zee S; Kanel P; Gerritsen MJJ; Boertien JM; Slomp AC; Müller MLTM; Bohnen NI; Spikman JM; van Laar T
    Mov Disord; 2022 Apr; 37(4):713-723. PubMed ID: 35037719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased ipsilateral [¹²³I]iododexetimide binding to cortical muscarinic receptors in unilaterally 6-hydroxydopamine lesioned rats.
    Knol RJ; de Bruin K; Opmeer B; Voorn P; Jonker AJ; van Eck-Smit BL; Booij J
    Nucl Med Biol; 2014 Jan; 41(1):90-5. PubMed ID: 24267055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.
    Colloby SJ; Pakrasi S; Firbank MJ; Perry EK; Piggott MA; Owens J; Wyper DJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Neuroimage; 2006 Nov; 33(2):423-9. PubMed ID: 16959499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson's disease.
    Gargouri F; Gallea C; Mongin M; Pyatigorskaya N; Valabregue R; Ewenczyk C; Sarazin M; Yahia-Cherif L; Vidailhet M; Lehéricy S
    Mov Disord; 2019 Apr; 34(4):516-525. PubMed ID: 30536444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson's disease.
    de Schipper LJ; van der Grond J; Marinus J; Henselmans JML; van Hilten JJ
    Neuroimage Clin; 2017; 15():587-593. PubMed ID: 28652971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gait-Related Metabolic Covariance Networks at Rest in Parkinson's Disease.
    Sigurdsson HP; Yarnall AJ; Galna B; Lord S; Alcock L; Lawson RA; Colloby SJ; Firbank MJ; Taylor JP; Pavese N; Brooks DJ; O'Brien JT; Burn DJ; Rochester L
    Mov Disord; 2022 Jun; 37(6):1222-1234. PubMed ID: 35285068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
    Asahina M; Suhara T; Shinotoh H; Inoue O; Suzuki K; Hattori T
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain activity alterations in patients with Parkinson's disease with cognitive impairment based on resting-state functional MRI.
    Guo W; Jin W; Li N; Gao J; Wang J; Chang Y; Yin K; Chen Y; Zhang S; Wang T
    Neurosci Lett; 2021 Mar; 747():135672. PubMed ID: 33515623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism.
    Feigin A; Antonini A; Fukuda M; De Notaris R; Benti R; Pezzoli G; Mentis MJ; Moeller JR; Eidelberg D
    Mov Disord; 2002 Nov; 17(6):1265-70. PubMed ID: 12465066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching.
    McCool MF; Patel S; Talati R; Ragozzino ME
    Neurobiol Learn Mem; 2008 Feb; 89(2):114-24. PubMed ID: 17709264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.